Bulletin
Investor Alert

New York Markets Open in:

Market Pulse Archives

Nov. 30, 2021, 6:40 a.m. EST

Merck, AstraZeneca's sNDA for breast cancer treatment granted priority review by the FDA

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Merck & Co. Inc. (MRK)
  • X
    AstraZeneca PLC ADR (AZN)
  • X
    E-Mini Dow Continuous Contract (YM00)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.20% and AstraZeneca PLC /zigman2/quotes/200304487/composite AZN +1.68% said Tuesday that their supplemental New Drug Application (sNDA) for its breast cancer treatment Lynparza has been accepted and granted priority review by the U.S. Food and Drug Administration. Lynparza's sNDA is for the adjuvant treatment of patients with BRCA-mutated, human epidermal growth factor receptor 2-negative high-risk early breast cancer who have already been treated with chemotherapy. The sNDA was based on results from a Phase 3 trial that showed Lynparza demonstrated a statistically significant and clinically meaningful improvement in invasive disease-free survival, reducing the risk of invasive breast cancer recurrence, second cancers or death by 42% versus placebo. Merck's stock slipped 0.2% in premarket trading, but outperformed the 1.2% drop in futures /zigman2/quotes/210407078/delayed YM00 +0.14% for the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.51% ahead of the open.

/zigman2/quotes/209956077/composite
US : U.S.: NYSE
$ 81.54
+0.16 +0.20%
Volume: 14.49M
Jan. 18, 2022 4:02p
P/E Ratio
28.79
Dividend Yield
3.38%
Market Cap
$205.56 billion
Rev. per Employee
$660,851
loading...
/zigman2/quotes/200304487/composite
US : U.S.: Nasdaq
$ 59.84
+0.99 +1.68%
Volume: 5.90M
Jan. 18, 2022 4:00p
P/E Ratio
94.44
Dividend Yield
2.29%
Market Cap
$181.14 billion
Rev. per Employee
$452,181
loading...
/zigman2/quotes/210407078/delayed
US : U.S.: CBOT
$ 35,308.00
+49.00 +0.14%
Volume: 59,670
Jan. 19, 2022 5:49a
loading...
/zigman2/quotes/210598065/realtime
US : Dow Jones Global
35,368.47
-543.34 -1.51%
Volume: 427.26M
Jan. 18, 2022 4:56p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.